Skip to main content
. 2020 Aug 26;19(1):2–8. doi: 10.1080/2090598X.2020.1814974

Table 1.

Descriptive analysis of the preoperative characteristics of 255 elderly patients treated with RC for UBC

Variable Value
Number of patients 255
Sex, n (%)  
Male 212 (83.1)
Female 43 (16.9)
Smoking, n (%)  
Never 66 (25.8)
Former 97 (38.1)
Current 92 (36.1)
Smoking intensity, n (%)  
Never 66 (25.8)
High 74 (29.1)
Low 115 (45.1)
Age at UBC diagnosis, years, median (IQR) 78 (74–82)
Age at RC, years, median (IQR) 79 (75–83)
Preoperative BMI, kg/m2, median (IQR) 23.4 (20.4–28.3)
Previous radiotherapy treatment, n (%)  
No 251 (98.4)
Yes 4 (1.6)
ECOG PS score, n (%)  
0 139 (54.5)
1 103 (40.4)
2 13 (5.1)
ASA score, median (IQR) 3 (2–4)
CCI score, median (IQR) 3 (2–4)
Clinical T stage, n (%)  
T1 12 (4.7)
T2 170 (67.2)
T3 56 (22.1)
T4 15 (5.9)
Clinical N stage, n (%)  
N0 241 (94.5)
N+ 14 (5.5)
Preoperative haemoglobin, g/dL, median (IQR) 13.2 (11.7–14.5)
Preoperative albumin, g/dL, median (IQR) 4.2 (3.9–4.4)
Preoperative CRP, mg/L, median (IQR) 8.8 (6.7–11.5)
mGPS, n (%)  
0 125 (49.0)
1 82 (32.2)
2 48 (18.8)
Hydronephrosis, n (%)  
No 189 (74.1)
Yes 66 (25.9)
Preoperative eGFR, mL/min/1.73 m2, median (IQR) 69.70 (49.27–89.70)
Preoperative fibrinogen level, mg/dL, median (IQR) 361 (299–442)
Preoperative NLR, median (IQR) 2.37 (1.61–3.53)
Preoperative total cholesterol level, mg/dL, median (IQR) 221 (187–263)
Preoperative HDL level, mg/dL, median (IQR) 49 (43–57)